ImmuPharma Commences Trading on the Stuttgart Stock Exchange

28th February 2013 - 9:13 am

ImmuPharma PLC (LSE: IMM), (“ImmuPharma” or the “Company”), the specialist drug discovery and development company, is pleased to announces that it has been informed by Baader Bank AG that its shares are now being traded on the third segment  of the Stuttgart Stock Exchange.

Baader Bank AG has experience and expertise for trading in German and non-German securities at Germany’s leading stock exchanges in Frankfurt, Berlin-Bremen, Munich and Stuttgart. They currently have more than 9,000 stocks from 56 countries including Coca-Cola, Citigroup, Sony and Singapore Airlines.

Dimitri Dimitriou, Chief Executive Officer of ImmuPharma commented: “We are delighted that we have further expanded our footprint into Europe with our shares now being traded on the Stuttgart Exchange. This should help dovetail efforts with our similar open market listing ‘Tradegate’ on the Berlin Exchange and we are confident that through these secondary European listings they will help support our UK Listing and assist in continuing to extend and strengthen our investor base.”

Share this article

Leave a comment